April 6, 2020
ObsEva sets up interim CFO
Switzerland-based ObsEva SA has nominated Fabien de Ladonchamps, Vice President Corporate Affairs & Finance, as interim Chief Financial Officer and member of the Executive Committee.
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
April 3, 2020
Novartis, Incyte test using Jakavi for respiratory problems in COVID-19 patients
Novartis said on Thursday it aims to start a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi (ruxolitinib) for the treatment of a type of severe immune overreaction called cytokine storm that can lead to life-threatening respiratory complications in patients with COVID-19.
April 3, 2020
Dupixent phase 3 testing has good result in atopic dermatitis
Sanofi and Regeneron’s phase 3 clinical trial results announced Friday show Dupixent (dupilumab) combined with standard-of-care topical corticosteroids (TCS) in children aged 6-11 years with uncontrolled severe atopic dermatitis significantly improved disease signs, symptoms and health-related quality of life.
April 2, 2020
Hygiena launches all-in-one Listeria, L. monocytogenes detection method
Hygiena, a global leader in rapid microbial detection, monitoring, and identification technology, introduced the InSite L. mono Glo Environmental Surface Screening Test. InSite L. mono Glo Environmental Surface Screening Test. InSite L. monoGlo is an easy-to-use, self-contained, environmental sampling and screening test for Listeria species and Listeria monocytogenes (L. mono).
April 2, 2020
– PBOA: Pharma industry, supply chain have positive outlook
The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, reports that many of its member companies are actively involved in helping their clients develop and produce treatments, vaccines, and diagnostics for COVID-19. PBOA’s members provide a wide array of services throughout the bio/pharma sector.
April 2, 2020
AiCuris screening of selected proprietary compounds to identify a possible drug candidate for the treatment of Covid-19
AiCuris Anti-infective Cures GmbH, a leading company in the discovery and development of drugs against infectious diseases gets involvedin the fight against SARS-CoV-2 (Corona).
April 2, 2020
PCR Biosystems makes 4M of COVID-19 test reagents daily
PCR Biosystems, the UK-based PCR experts, PCR Biosystems has the capacity to manufacture enough reagent daily for 4 million reactions – which is sufficient for millions of diagnostic tests
April 2, 2020
Austrian Aperion OKd to phase2 test APN01 to treat COVID-19 in 3 EU countries
Apeiron Biologics AG has received regulatory approvals in Austria, Germany and Denmark to kickoff a Phase II clinical trial of APN01 to treat COVID-19.
April 1, 2020
InflaRx enrolls patient to test its antibody in COVID-19-induced pneumonia
German biopharmaceutical company InflaRx has enrolled the first patient into a randomized clinical trial investigating the safety and efficacy of IFX-1, the company´s monoclonal anti-C5a antibody, in patients with severe COVID-19-induced pneumonia.
March 31, 2020
Ritedose selects ChargePoint Technology’s transfer solution for biomanufacturing project
The Ritedose Corporation, a contract development and manufacturing organisation (CDMO) with a focus on inhalation and ophthalmic products, has partnered…